Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "BeST"

836 News Found

Aleor Dermaceuticals receives USFDA approval for Clobestasol
Drug Approval | April 25, 2022

Aleor Dermaceuticals receives USFDA approval for Clobestasol

Clobetasol Propionate Foam, 0.05% has an estimated market size of US $ IO million for twelve months ending Dec 2021 according to IQVIA


Thermo Fisher Scientific’s Clinical Research Business named `Best CRO’ at Vaccine Excellence awards
Biotech | April 22, 2022

Thermo Fisher Scientific’s Clinical Research Business named `Best CRO’ at Vaccine Excellence awards

The business is a recognized leader in managing Covid-19 and mRNA research programs


GenScript wins Best CDMO award for the third time
News | March 30, 2022

GenScript wins Best CDMO award for the third time

The award also follows GenScript's recognition at the Korea Bioprocessing Excellence Awards in 2021 for the "Best Contract Development and Manufacturing Organization Award".


Modis and ValGenesis partner to bring Best-in-Class validation processes to Italian pharma
Digitisation | February 18, 2022

Modis and ValGenesis partner to bring Best-in-Class validation processes to Italian pharma

The partnership will help digitize and automate existing tasks traditionally managed on paper, significantly reducing costs and lead times while increasing compliance


Molnupiravir best option to treat Covid-19 now: Experts
News | January 11, 2022

Molnupiravir best option to treat Covid-19 now: Experts

Health experts of the country have pointed out that the benefits of the drug outweigh the potential risks it may have in the case of high-risk patients


NITI Aayog launches report on best practices in district hospitals
Public Health | October 01, 2021

NITI Aayog launches report on best practices in district hospitals

A total of 707 district hospitals across all states and union territories participated in the performance assessment. The Health Management Information System (HMIS) data for the year 2017–18 has been used as a baseline for this exercise


Insilico Medicine’s AI-designed Parkinson’s drug cleared for human trials by FDA
Clinical Trials | January 29, 2026

Insilico Medicine’s AI-designed Parkinson’s drug cleared for human trials by FDA

The upcoming Phase I trial will test the safety, tolerability, and pharmacokinetics of ISM8969 in healthy volunteers and determine the optimal dosing for future studies


Eyestem moves closer to blindness breakthrough with phase 2 trial green light
R&D | January 29, 2026

Eyestem moves closer to blindness breakthrough with phase 2 trial green light

The early-stage trial demonstrated an excellent safety profile alongside clinically meaningful improvements in visual acuity


Lupin receives highest ESG rating from CDP for climate change and water security
Sustainability | January 24, 2026

Lupin receives highest ESG rating from CDP for climate change and water security

Lupin’s double ‘A’ rating in Climate and Water exemplifies its steadfast commitment to sustainability


Akeso’s novel AS drug Gumokimab accepted for review by China’s drug regulator
News | January 23, 2026

Akeso’s novel AS drug Gumokimab accepted for review by China’s drug regulator

This marks the second indication for which gumokimab has gained NDA review acceptance